BE890230A - Compositions pharmaceutiques accelerant la guerison de blessures - Google Patents

Compositions pharmaceutiques accelerant la guerison de blessures

Info

Publication number
BE890230A
BE890230A BE0/205872A BE205872A BE890230A BE 890230 A BE890230 A BE 890230A BE 0/205872 A BE0/205872 A BE 0/205872A BE 205872 A BE205872 A BE 205872A BE 890230 A BE890230 A BE 890230A
Authority
BE
Belgium
Prior art keywords
pharmaceutical compositions
wound healing
accelerating wound
accelerating
healing
Prior art date
Application number
BE0/205872A
Other languages
English (en)
French (fr)
Original Assignee
Geistlich Soehne Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Geistlich Soehne Ag filed Critical Geistlich Soehne Ag
Publication of BE890230A publication Critical patent/BE890230A/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38—Cellulose; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L26/00—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form
    • A61L26/0061—Use of materials characterised by their function or physical properties
    • A61L26/0066—Medicaments; Biocides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L26/00—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form
    • A61L26/0061—Use of materials characterised by their function or physical properties
    • A61L26/008—Hydrogels or hydrocolloids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/20—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing organic materials
    • A61L2300/21—Acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/20—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing organic materials
    • A61L2300/21—Acids
    • A61L2300/214—Amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
    • A61L2300/45—Mixtures of two or more drugs, e.g. synergistic mixtures

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Inorganic Chemistry (AREA)
  • Materials Engineering (AREA)
  • Engineering & Computer Science (AREA)
  • Dispersion Chemistry (AREA)
  • Dermatology (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
BE0/205872A 1980-09-04 1981-09-04 Compositions pharmaceutiques accelerant la guerison de blessures BE890230A (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB8028554 1980-09-04

Publications (1)

Publication Number Publication Date
BE890230A true BE890230A (fr) 1982-01-04

Family

ID=10515840

Family Applications (1)

Application Number Title Priority Date Filing Date
BE0/205872A BE890230A (fr) 1980-09-04 1981-09-04 Compositions pharmaceutiques accelerant la guerison de blessures

Country Status (15)

Country Link
EP (1) EP0047647B1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
JP (1) JPS5780316A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
AU (1) AU7486081A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
BE (1) BE890230A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
CA (1) CA1198679A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
CH (1) CH650148A5 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
DE (1) DE3173310D1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
DK (1) DK390181A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
ES (1) ES8307491A1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
FI (1) FI812708L (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
FR (1) FR2489145A1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
GB (1) GB2082911B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
IT (1) IT1209894B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
NZ (1) NZ198259A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
ZA (1) ZA816124B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0302536B1 (en) * 1982-04-22 1992-11-19 E.R. Squibb & Sons, Inc. Granules for use in treating wounds
US4604384A (en) * 1982-06-24 1986-08-05 Smith Robert A Pharmaceutical gel composition
GR79380B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) * 1982-09-28 1984-10-22 Johnson & Johnson Prod Inc
EP0137743A3 (en) * 1983-09-13 1986-10-01 Ed. Geistlich Söhne Ag Für Chemische Industrie Topically administrable pharmaceutical compositions
DD248961A1 (de) * 1984-05-22 1987-08-26 Akad Wissenschaften Ddr Verfahren zur herstellung wundheilungsfoerdernder praeparationen
EP0274532B1 (en) * 1986-06-13 1992-09-09 Japan Immuno Research Laboratories Co., Ltd. Wound-healing drug and cosmetics
EP0321709A3 (en) * 1987-12-23 1990-04-04 Francisco José Izundegui MacDonnell Fast healing and binding chemical compound or curative agent for healing wounded live animal and human soft tissues inflicted by cutting edges or separating forces
US4871718A (en) * 1987-12-29 1989-10-03 Raymond A. Roncari Composition of matter for increasing intracellular ATP levels and physical performance levels and for increasing the rate of wound repair
GB2276819B (en) * 1993-03-23 1996-12-11 Johnson & Johnson Medical Aqueous wound treatment composition comprising a polysaccharide and hexylene glycol
US5670169A (en) * 1993-12-20 1997-09-23 E.R. Squibb & Sons, Inc. Wound hydrating gel with novel preservative system and low cytotoxicity
GB2291348B (en) * 1994-07-18 1999-01-20 Johnson & Johnson Medical Sterile gel composition for wound treatment comprising alginate and polyhydric alcohol
RU2165754C2 (ru) * 1997-04-02 2001-04-27 Мчедлидзе Тамаз Шалвович Мазь для лечения гнойновоспалительных заболеваний, ожогов, воспалительных заболеваний суставов, трофических язв и длительно незаживающих ран, способ ее приготовления и способ лечения
WO1998043613A1 (fr) * 1997-04-02 1998-10-08 Tamaz Shalvovich Mchedlidze Onguents pour traiter tous les stades de lesions suppuratives, brulures et ulcers trophiques, modes de preparation et applications
RU2138250C1 (ru) * 1997-06-23 1999-09-27 ОАО "Нижегородский химико-фармацевтический завод" Способ получения мази "диоксиколь"
RU2146921C1 (ru) * 1997-11-05 2000-03-27 Рязанский областной клинический кожно-венерологический диспансер Мазевая композиция, стимулирующая регенерацию эпителия
RU2146923C1 (ru) * 1997-11-05 2000-03-27 Рязанский областной клинический кожно-венерологический диспансер Средство для лечения дерматозов
RU2145497C1 (ru) * 1998-04-16 2000-02-20 Государственный научный центр лекарственных средств Средство для лечения гнойно-некротических процессов
RU2135180C1 (ru) * 1999-02-15 1999-08-27 Фармацевтическое научно-производственное предприятие "Ретиноиды" (акционерное общество закрытого типа) Мазь для заживления ран
US7514097B1 (en) 1999-11-09 2009-04-07 Denki Kagaku Kogyo Kabushiki Kaisha Use of soluble cellulose derivative having been made hardly soluble in water and process for producing the same
WO2002094256A1 (en) * 2001-05-23 2002-11-28 Debatosh Datta Lysine and/or analogues and/or polymers thereof for promoting wound healing and angiogenesis
RU2349302C1 (ru) * 2007-09-21 2009-03-20 Виталий Георгиевич Пшеничников Фармацевтическая композиция для наружного применения "офломелид" при гнойно-воспалительных заболеваниях
US10413528B2 (en) * 2014-10-20 2019-09-17 John H. Plumb Methods to inhibit infection during wound healing with topical compositions including amino acids
WO2019035953A1 (en) 2017-08-18 2019-02-21 Calwood Nutritionals, Llc COMPOSITIONS AND METHODS FOR INCREASING MUSCLE MASS AND MUSCLE STRENGTH, TREATING SKIN, REDUCING WEAR AND DEGRADING FROM AGING AND EXPOSURE AND ENHANCING RECOVERY OF A STRESS SUCH AS EXERCISE AND TRAUMA
RU2733714C2 (ru) * 2017-11-07 2020-10-06 Общество с ограниченной ответственностью "Трейдсервис" Стабильная комбинированная фармацевтическая композиция диоксидина и анестетиков

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3786076A (en) * 1966-10-13 1974-01-15 J Morelle Lipoaminoacids
FR2215212B1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) * 1973-01-18 1976-03-05 Seperic Ch
DE2438703C3 (de) * 1974-08-12 1980-02-21 Ernst Dr.Med. 4970 Bad Oeynhausen Lauven Verwendung einer Mischung bei der Rheumabehandlung

Also Published As

Publication number Publication date
JPS5780316A (en) 1982-05-19
ES505172A0 (es) 1983-07-01
GB2082911B (en) 1984-04-18
IT8149222A0 (it) 1981-09-03
IT1209894B (it) 1989-08-30
FR2489145B1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 1984-05-25
DE3173310D1 (en) 1986-02-06
NZ198259A (en) 1985-05-31
GB2082911A (en) 1982-03-17
AU7486081A (en) 1982-03-11
EP0047647B1 (en) 1985-12-27
FI812708A7 (fi) 1982-03-05
CH650148A5 (fr) 1985-07-15
DK390181A (da) 1982-03-05
FI812708L (fi) 1982-03-05
ZA816124B (en) 1982-09-29
EP0047647A3 (en) 1982-09-15
FR2489145A1 (fr) 1982-03-05
EP0047647A2 (en) 1982-03-17
CA1198679A (en) 1985-12-31
ES8307491A1 (es) 1983-07-01

Similar Documents

Publication Publication Date Title
BE890230A (fr) Compositions pharmaceutiques accelerant la guerison de blessures
FI812709A7 (fi) Luutulehduksen hoito.
FR2547727B1 (fr) Compositions pharmaceutiques
BE864726A (fr) Compositions pharmaceutiques contenant de la cholestyramine
DK412480A (da) Menstruationstamponer
PT73686A (pt) Pharmaceutical formulation
NO1998011I1 (no) Tiludronsyre
AR231899A1 (es) Composicion insecticida sinergistica
AR227435A1 (es) Composicion dental
IT1162879B (it) Composizioni farmaceutiche
FI810056L (fi) Farmaceutiska foereningar
IT1207106B (it) Preparazione farmaceutica contenente citidin disfofocolina assorbibile per via orale
IT8267345A0 (it) Composto e composizione farmaceutica per accelerare la cicatrizzazione di ferite
FR2527078B1 (fr) Compositions pharmaceutiques anti-ulceres
FI832520A7 (fi) Farmaseuttisia menetelmiä ja koostumuksia.
MX6962E (es) Procedimiento para la preparacion de una composicion farmaceutica antidiarreica
MC1371A1 (fr) Preparations pharmaceutiques
MC1372A1 (fr) Preparations pharmaceutiques
IT8048854A0 (it) Alcossi-acil carnitine procedimento per la loro preparazione e composizioni farmaceutiche che le contengono
BE891013A (fr) Compositions pharmaceutique
IT1171389B (it) Composti amminosteroidi composizioni farmaceutiche che li contengono e procentimento per prepararli
DK391383A (da) Acylerede isoxazolylurinstoffer
IT8348518A0 (it) Piperidinoguanidine sostituite,procedimento per la loro preparazione e composizioni farmaceutiche che le contengono
DK251684D0 (da) Enterostomibandage
RO78607A2 (ro) Compozitie medivamentoasa hipolipemianta-antiaterosclerotica

Legal Events

Date Code Title Description
RE Patent lapsed

Owner name: ED. GEISTLICH SOHNE A.G. FUR CHEMISCHE INDUSTRIE

Effective date: 19860930